The R.I. Life Science Hub is leading development of our state’s first life science incubator, and is already generating a great return on our investment, writes House Speaker K. Joseph Shekarchi ...

Despite staffing cuts at CMS, Organogenesis expects to manage through the challenges. Click here to read why I rate ORGO ...

A negotiation for a tax stabilization agreement (TSA) between Smithfield and the biomedical company Organogenesis may be off to an unstable start, but the town and company seem ...

Rhumbline Advisers grew its holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO – Free Report) by 7.1% during the 4th ...

As the U.S. stock market rebounds from recent tariff-related volatility, investors are keenly observing companies with solid fundamentals and strong insider confidence. In this landscape, growth ...

Mackenzie Financial Corp lifted its stake in Organogenesis by 255.1% during the fourth quarter. Mackenzie Financial Corp now owns 76,353 shares of the company’s stock valued at $244,000 after ...

Welcome, ladies and gentlemen to the fourth quarter and fiscal year 2024, earnings conference call for Organogenesis Holdings Inc. (Operator Instructions) Before we begin, I would like to remind ...

Learn more here. Operator Welcome, ladies and gentlemen, to the fourth quarter and fiscal year 2024 earnings conference call ...

Welcome, ladies and gentlemen, to the fourth quarter and fiscal year 2024 earnings conference call for Organogenesis Holdings, Inc. At this time, all participants have been placed in listen-only mode.

Gillheeney, Sr., President, Chief Executive Officer and Chair of the Board for Organogenesis. "In 2025, we will continue to focus on our customers while we collaborate with policy and law makers to ...